期刊
PHARMACOGENOMICS
卷 5, 期 4, 页码 381-394出版社
FUTURE MEDICINE LTD
DOI: 10.1517/14622416.5.4.381
关键词
bladder cancer; early detection; premalignant lesions; protein profiles; therapeutic targets; translational research; tumor interstitial fluid; urine markers
Detecting bladder cancer at an early stage and predicting how a tumor will behave and act in response to therapy, as well as the identification of new targets for therapeutic intervention, are among the main areas of research that will benefit from the current explosion in the number of powerful technologies emerging within proteomics. The purpose of this article is to briefly review what has been achieved to date using proteomic technologies and to bring forward novel strategies - based on the analysis of clinically relevant samples - that promise to accelerate the translation of basic discoveries into the daily clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据